GOLDMAN SACHS GROUP INC - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 142 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$238,000
-47.5%
70,113
-41.8%
0.00%
Q2 2018$453,000
-89.2%
120,538
-88.3%
0.00%
-100.0%
Q1 2018$4,205,000
+25.7%
1,027,998
+42.9%
0.00%0.0%
Q4 2017$3,346,000
-37.2%
719,523
-4.2%
0.00%0.0%
Q3 2017$5,332,000
+0.3%
750,953
+2.1%
0.00%0.0%
Q2 2017$5,318,000
+21.8%
735,573
+3.8%
0.00%0.0%
Q1 2017$4,366,000
+2.5%
708,862
-2.5%
0.00%0.0%
Q4 2016$4,259,000
+22.7%
726,774
+11.2%
0.00%0.0%
Q3 2016$3,470,000
-17.0%
653,420
+3.4%
0.00%0.0%
Q2 2016$4,181,000
+85.6%
631,662
+30.9%
0.00%
Q1 2016$2,253,000
+360.7%
482,533
+398.1%
0.00%
Q4 2015$489,000
-88.2%
96,871
-91.8%
0.00%
-100.0%
Q3 2015$4,158,000
-28.0%
1,181,129
+104.3%
0.00%0.0%
Q2 2015$5,771,000
+26.0%
578,206
+60.6%
0.00%0.0%
Q1 2015$4,581,000
+108.5%
359,938
+131.8%
0.00%
Q4 2014$2,197,000
-65.4%
155,285
-66.4%
0.00%
-100.0%
Q3 2014$6,354,000
+82.2%
462,096
+103.8%
0.00%
+200.0%
Q2 2014$3,488,000
-34.5%
226,795
-27.4%
0.00%
-50.0%
Q1 2014$5,322,000
-64.1%
312,335
-72.7%
0.00%
-60.0%
Q4 2013$14,808,000
+27.2%
1,143,408
-0.9%
0.01%
+25.0%
Q3 2013$11,639,000
-24.0%
1,153,458
-43.8%
0.00%
-33.3%
Q2 2013$15,324,000
+1203.1%
2,051,390
+357.3%
0.01%
Q4 2012$1,176,000
+439.4%
448,592
+479.8%
0.00%
Q3 2012$218,000
+61.5%
77,374
+3.5%
0.00%
Q2 2012$135,000
-92.1%
74,737
-78.3%
0.00%
-100.0%
Q1 2012$1,713,000343,8480.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders